Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs
LaTonya Mitchell, Director, Food and Drug Administration (FDA) Denver District Office; and Dr. Ilisa Bernstein, Acting Director, FDA Office of Compliance to Richard Matmer, Nutri Fusion Systems LLC
Date
By
Mary K. Engle, Associate Director